Categories: India

UPDATE 1-UniQure's Huntington's therapy fails to significantly slow disease progression, shares plunge

(Updates shares, adds trial details and background in paragraphs 2, 3) Sept 29 (Reuters) – UniQure said its gene therapy for Huntington's disease fell short of statistical significance on the main

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Nvidia approached Arm CEO Haas to succeed Huang, FT reports

Nov 13 (Reuters) - Nvidia's board has approached British chipmaker Arm Holdings CEO Rene Haas…

2 seconds ago

UPDATE 1-Fed likely to need to raise rates amid worsening inflation: Daly

(Adds comments, context starting in paragraph 3) * Services inflation moving in the wrong direction,…

6 minutes ago

Royal Champion races to Bahrain International Trophy win

VIDEO SHOWS: BAHRAIN INTERNATIONAL TROPHY HORSE RACING HIGHLIGHTS COMPLETE SCRIPT TO FOLLOW SHOWS: RIFFA, BAHRAIN…

7 minutes ago

Nvidia approached Arm CEO Haas to succeed Huang, FT reports

Nov 13 (Reuters) - Nvidia's board has approached British chipmaker Arm Holdings CEO Rene Haas…

10 minutes ago

Nvidia approached Arm CEO Haas to succeed Huang, FT reports

Nov 13 (Reuters) - Nvidia's board has approached British chipmaker Arm Holdings CEO Rene Haas…

11 minutes ago

UPDATE 1-Paraguay adds criminal association charge against ex-president Peña

(Adds detail from prosecutor's document) By Daniela Desantis ASUNCION, Nov 13 (Reuters) - The Paraguay…

16 minutes ago